The board of directors of TOT BIOPHARM International Company Limited announced that Dr. Liu, Jun has been appointed as the chief operating officer of the Company with effect from 21 April 2020. Dr. Liu will be fully responsible for the management of the Group's operations, as well as assisting the general manager in promoting the development of overseas operations. Dr. Liu joined the Group on 17 October 2016 as a vice general manager, and has served as an executive director and chief scientific officer of the Company since October 2018 and March 2019 respectively. He is responsible for the research and development (R&D) and quality control of products. With Dr. Liu's vast experience of overseas R&D and management, the Board believes that the appointment of Dr. Liu as COO will be conducive to improving and enhancing the Group's internal collaboration between R&D and production in preparation for its entry into the phase of commercialization development in the future, and at the same time strengthening the Group's exploration of overseas R&D and international collaboration projects.